Spinal Cord Stimulation (SCS) Implantable Pulse Generator (IPG)
ABBOTT MEDICAL · Decision date Jul 26, 2026
What did the FDA decide?
FDA records P010032/S259 as a supplement to PMA P010032, with the supplement type “30-Day Notice”. The recorded decision is OK30 (30-day notice), dated Jul 26, 2026.
FDA approval order statement
to utilize alternate drop-in diode components in the Printed Circuit Board Assemblies of its Implantable Pulse Generators
- Regulatory pathway
- PMA supplement
- Supplement type
- 30-Day Notice
- Clinical specialty
- Neurology
- Decision date
- Jul 26, 2026
- FDA change category
- Process Change - Manufacturer/Sterilizer/Packager/Supplier
Regulatory record facts
- Identifier
- P010032/S259
- Regulatory pathway
- PMA supplement
- Applicant
- ABBOTT MEDICAL
- Product code
- LGW
- Decision code
- OK30
- Decision date
- Jul 26, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Stimulator, spinal-cord, totally implanted for pain relief.
- Applicant
- Abbott Medical
- Product code
- LGW
- FDA device class
- 3
For the original device and its historical approval scope, see PMA P010032. Subsequent supplements may change the device or its indications.
FDA decision timeline
P010032 · Original PMA
GENESIS AND EON FAMILY NEUROSTIMULATION (IPG) SYSTEMS
P010032/S236 · Related supplement
Eterna SCS IPG (Model 32400)
P010032/S242 · Related supplement
Proclaim Spinal Cord Stimulation (SCS) Implantable Pulse Generator (IPG)
P010032/S240 · Related supplement
Eterna SCS IPG
P010032/S244 · Related supplement
SCS Neurostimulation System
P010032/S241 · Related supplement
Proclaim SCS System
P010032/S243 · Related supplement
Spinal Cord Stimulation (SCS) Neurostimulation System
P010032/S246 · Related supplement
Proclaim Spinal Cord Stimulation (SCS) System
P010032/S237 · Related supplement
Eterna SCS and Proclaim SCS Systems
P010032/S247 · Related supplement
Spinal Cord Stimulation (SCS) Implantable Pulse Generator (IPG)
P010032/S245 · Related supplement
8-channel adapter, M, 10cm; 8-channel adapter, M, 60cm; 8-channel adapter, B, 10cm; 8-channel adapter, B, 60cm; Legacy M
P010032/S248 · Related supplement
Proclaim Spinal Cord Stimulation (SCS) Implantable Pulse Generator (IPG)
P010032/S249 · Related supplement
Spinal Cord Stimulation (SCS) Implantable Pulse Generator (IPG)
P010032/S250 · Related supplement
Proclaim Spinal Cord Stimulation (SCS) Implantable Pulse Generator (IPG); Eterna SCS IPG
P010032/S252 · Related supplement
Spinal Cord Stimulation (SCS) Implantable Pulse Generator (IPG)
P010032/S259 received
Application receipt date recorded by FDA.
P010032/S253 · Related supplement
Etema Spinal Cord Stimulation (SCS) Implantable Pulse Generator (IPG)
P010032/S255 · Related supplement
Spinal Cord Stimulation (SCS) Implantable Pulse Generator (IPG)
P010032/S259 · FDA decision
30-Day Notice
P010032/S254 · Related supplement
Spinal Cord Stimulation (SCS) Implantable Pulse Generator (IPG)
P010032/S261 · Related supplement
Spinal Cord Stimulation (SCS) Implantable Pulse Generator (IPG) Charger
P010032/S251 · Related supplement
Quattrode; Octrode; Penta; Lamitrode; Tripole; TriCentrus Lead Extensions
P010032/S260 · Related supplement
Proclaim family of SCS IPG
P010032/S265 · Related supplement
Eterna Spinal Cord Stimulation (SCS) Implantable Pulse Generator
P010032/S262 · Related supplement
Spinal Cord Stimulation (SCS) External Pulse Generator (EPG)
P010032/S264 · Related supplement
Spinal Cord Stimulation (SCS) Implantable Pulse Generator (IPG) Charger
P010032/S266 · Related supplement
Spinal Cord Stimulation (SCS) Implantable Pulse Generator (IPG)
Timeline entries are records held by MedtechLedger for P010032. View FDA’s full supplement list.
Related devices and submissions
Same PMA: P010032
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
| ABBOTT MEDICAL | PMA approval | Nov 21, 2001 | FDA | |
Eterna SCS IPG (Model 32400)P010032/S236 | ABBOTT MEDICAL | PMA supplement | Jul 28, 2025 | FDA |
| ABBOTT MEDICAL | PMA supplement | Aug 29, 2025 | FDA | |
Eterna SCS IPGP010032/S240 | ABBOTT MEDICAL | PMA supplement | Sep 7, 2025 | FDA |
SCS Neurostimulation SystemP010032/S244 | ABBOTT MEDICAL | PMA supplement | Sep 25, 2025 | FDA |
Proclaim SCS SystemP010032/S241 | ABBOTT MEDICAL | PMA supplement | Sep 26, 2025 | FDA |
| ABBOTT MEDICAL | PMA supplement | Nov 7, 2025 | FDA | |
Proclaim Spinal Cord Stimulation (SCS) SystemP010032/S246 | ABBOTT MEDICAL | PMA supplement | Dec 23, 2025 | FDA |
Eterna SCS and Proclaim SCS SystemsP010032/S237 | ABBOTT MEDICAL | PMA supplement | Jan 13, 2026 | FDA |
| ABBOTT MEDICAL | PMA supplement | Feb 10, 2026 | FDA | |
| ABBOTT MEDICAL | PMA supplement | Feb 11, 2026 | FDA | |
| ABBOTT MEDICAL | PMA supplement | Mar 13, 2026 | FDA | |
| ABBOTT MEDICAL | PMA supplement | Apr 25, 2026 | FDA | |
| ABBOTT MEDICAL | PMA supplement | Apr 30, 2026 | FDA | |
| ABBOTT MEDICAL | PMA supplement | May 26, 2026 | FDA | |
| ABBOTT MEDICAL | PMA supplement | Jul 2, 2026 | FDA | |
| ABBOTT MEDICAL | PMA supplement | Jul 17, 2026 | FDA | |
| ABBOTT MEDICAL | PMA supplement | Aug 7, 2026 | FDA | |
| ABBOTT MEDICAL | PMA supplement | Sep 11, 2026 | FDA | |
| ABBOTT MEDICAL | PMA supplement | Sep 18, 2026 | FDA | |
Proclaim family of SCS IPGP010032/S260 | ABBOTT MEDICAL | PMA supplement | Sep 23, 2026 | FDA |
| ABBOTT MEDICAL | PMA supplement | Oct 27, 2026 | FDA | |
| ABBOTT MEDICAL | PMA supplement | Oct 28, 2026 | FDA | |
| ABBOTT MEDICAL | PMA supplement | Oct 30, 2026 | FDA | |
| ABBOTT MEDICAL | PMA supplement | Oct 30, 2026 | FDA |
Explore the linked device profile
Other records with product code LGW
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
| Medtronic Neuromodulation | PMA supplement | Oct 30, 2026 | FDA | |
| Medtronic Neuromodulation | PMA supplement | Oct 29, 2026 | FDA | |
Saluda Medical Evoke SCS SystemP190002/S052 | Saluda Medical Pty, Ltd. | PMA supplement | Oct 16, 2026 | FDA |
Saluda Medical Evoke SCS SystemP190002/S051 | Saluda Medical Pty, Ltd. | PMA supplement | Oct 15, 2026 | FDA |
| Medtronic Neuromodulation | PMA supplement | Oct 6, 2026 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Abbott Medical
- Headquarters
- Not reported
- Brand website
- abbott.com
- FDA applicant address
- 6901 Preston Rd., Plano, TX, 75024
Sources and methodology
- Original FDA record: P010032/S259
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 21, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records







